The pharmacodynamic study of a potent new antimalarial (MC1). Satayavivad J, Watcharasit P, Khamkong P, Tuntawiroon J, Pavaro C, Ruchirawat S Acta Tropica 2004; 89: 343-9.

01 Feb 2004
0

The pharmacodynamic study of a potent new antimalarial (MC1).
Satayavivad J, Watcharasit P, Khamkong P, Tuntawiroon J, Pavaro C, Ruchirawat S
Acta Tropica 2004; 89: 343-9.

Tags

Share this

Related Posts

Palakhachane, S.; Ketkaew Y.; Chuaypen, N.; Sirirak, J.; Boonsombat, J.; Ruchirawat, S.; Tangkijvanich, P.; Suksamrarn, A.; Limpachayaporn, P. Synthesis of Sorafenib Analogues Incorporating a 1,2,3-Triazole Ring and Cytotoxicity towards Hepatocellular Carcinoma Cell Lines. Bioorg. Chem. 2021, 112, 104831.
Kanintronkul, Y; Worayuthakarn, R; Thasana, N; Winayanuwattikun, P; Pattanapanyasat, K; Surarit, R; Ruchirawat, S; Svasti, J. Overcoming Multidrug Resistance in Human Lung Cancer with Novel Benzo[a]quinolizin-4-ones. Anticancer Res. 2011, 31, 921–928.

Recent Posts